Best of the Week
Most Popular
1. US Housing Market House Prices Bull Market Trend Current State - Nadeem_Walayat
2.Gold and Silver End of Week Technical, CoT and Fundamental Status - Gary_Tanashian
3.Stock Market Dow Trend Forecast - April Update - Nadeem_Walayat
4.When Will the Stock Market’s Rally Stop? - Troy_Bombardia
5.Russia and China Intend to Drain the West of Its Gold - MoneyMetals
6.BAIDU (BIDU) - Top 10 Artificial Intelligence Stocks Investing To Profit from AI Mega-trend - Nadeem_Walayat
7.Stop Feeding the Chinese Empire - ‘Belt and Road’ Trojan Horse - Richard_Mills
8.Stock Market US China Trade War Panic! Trend Forecast May 2019 Update - Nadeem_Walayat
9.US China Trade Impasse Threatens US Lithium, Rare Earth Imports - Richard_Mills
10.How to Invest in AI Stocks to Profit from the Machine Intelligence Mega-trend - Nadeem_Walayat
Last 7 days
The Bad News About Record-Low Unemployment - 24th June 19
Stock Market New High, but…! - 24th June 19
Formula for when the Great Stock Market Rally Ends - 24th June 19
How To Time Market Tops and Bottoms - 24th June 19
5 basic tips to help mitigate the vulnerability inherent in email communications - 24th June 19
Will Google AI Kill Us? Man vs Machine Intelligence - 24th June 19
Why are Central Banks Buying Gold and Dumping Dollars? - 23rd June 19
Financial Sector Paints A Clear Picture For Stock Market Trading Profits - 23rd June 19
What You Should Look While Choosing Online Casino - 23rd June 19
INTEL (INTC) Stock Investing to Profit From AI Machine Learning Boom - 22nd June 19
Here’s Why You Should Drive a Piece of Crap Car - 22nd June 19
How Do Stock Prices React to Fed Interest Rate Cuts? - 22nd June 19
Gold Bull Market Breaking Out! - 21st June 19
Post-FOMC Commentary: Delusions of Grandeur - 21st June 19
Gold Scores Gains as Draghi and Powel Grow Concerned - 21st June 19
Potential Upside Targets for Gold Stocks - 21st June 19
Gold Price Trend Forcast to End September 2019 - 21st June 19
The Gold (and Silver) Volcano Is Ready to Erupt - 21st June 19
Fed Leaves Rates Unchanged – Gold & Stocks Rally/Dollar Falls - 21st June 19
Silver Medium-Term Trend Analysis - 20th June 19
Gold Mining Stocks Waiting on This Chart - 20th June 19
A Key Gold Bull Market Signal - 20th June 19
Money Saving Kids Gardening Growing Giant Sunflowers Summer Fun - 20th June 19
Investing in APPLE (AAPL) to Profit From AI Machine Learning Stocks - 20th June 19
Small Cap Stocks May Lead A Market Rally - 20th June 19 -
Interest Rates Square Minus Zero - 20th June 19
Advice for Financing a Luxury Vehicle - 20th June 19
Stock Market Final Blow Off Top Just Hit… Next Week Comes the FIREWORKS - 20th June 19
US Dollar Rallies Off Support But Is This A Top Or Bottom? - 19th June 19
Most Income Investors Are Picking Up Nickels in Front of a Steamroller - 19th June 19
Is the Stock Market’s Volatility About to Spike? - 19th June 19
Facebook's Libra Crypto currency vs Bitcoin: Five Key Differences - 19th June 19
Fed May Trigger Wild Swing In Stock Index and Precious Metals - 19th June 19
How Long Do Land Rover Discovery Sport Brake Pads Last? - 19th June 19
Gold Golden 'Moment of Truth' Is Upon Us: $1,400-Plus or Not? - 18th June 19
Exceptional Times for Gold Warrant Special Attention - 18th June 19
The Stock Market Has Gone Nowhere and Volume is Low. What’s Next - 18th June 19
Silver Long-Term Trend Analysis - 18th June 19
IBM - Watson Deep Learning - AI Stocks Investing - Video - 18th June 19
Investors are Confident, Bullish and Buying Stocks, but… - 18th June 19
Gold and Silver Reversals – Impossible Not to Notice - 18th June 19
S&P 500 Stuck at 2,900, Still No Clear Direction - 17th June 19
Is Boris set to be the next Conservation leader? - 17th June 19
Clock’s Ticking on Your Chance to Profit from the Yield Curve Inversion - 17th June 19
Stock Market Rally Faltering? - 17th June 19
Johnson Vs Gove Tory Leadership Contest Grudge Match Betfair Betting - 17th June 19
Nasdaq Stock Index Prediction System Is Telling Us A Very Different Story - 17th June 19
King Dollar Rides Higher Creating Pressures On Foreign Economies - 17th June 19
Land Rover Discovery Sport Tailgate Not Working Problems Fix (70) - 17th June 19
Stock Market Outlook: is the S&P today just like 2007 or 2016? - 17th June 19

Market Oracle FREE Newsletter

Gold Price Trend Forecast Summer 2019

The One Stocks Indicator to Watch as More Bubbles Burst

Companies / BioTech Sep 28, 2015 - 08:20 AM GMT

By: ...


Michael E. Lewitt writes: One by one, the bubbles are bursting…

First it was the commodities bubble that blew up in mid-2014, which caused the collapse of energy and commodity stocks -they are now down between 40-80%.

It also caused the end of the corporate credit bubble in high yield bonds and bank loans over the second half of 2014 and into this year.

Then the Chinese stock market, which had gone parabolic early this year, collapsed, sending global markets into a tailspin this summer.

Last week we saw the bursting of another bubble – the biotech bubble. Starting April 7, 2014, the iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) almost doubled, rising from $215.46 per share to a high of $397.59 per share on July 13, 2015.

Needless to say, it was cheered on by breathless Wall Street analysts who were paraded on CNBC to explain why investors should run out and mortgage their houses to buy even more of these overvalued stocks. This was a replay of the Internet Bubble. It was an invitation to lose lots of money.

But a funny thing happened on the way to the insane asylum – reality intervened. And since July 14, IBB has traded back down to $310.20 per share – a loss of 22%. Last week alone, it dropped 13%, including a 5.1% collapse on Friday. Financial media are blaming Hillary Clinton's complaints about high drug prices for the drop, but that is just an excuse. Investors are waking up to the fact that biotech stock prices had no relationship to reality.

For the Decline in Biotech, Thank the Usual Suspects

I told readers of my newsletter to short IBB at the start of 2015 when it was trading at around $300 per share. And as it continued to move higher, I maintained my view that it would collapse under the weight of the delusions pushing it higher.

You see, the biotech bubble had very little to do with biotech. But it had everything to do with the confederacy of dunces known as the Federal Reserve. Biotech stocks were a beneficiary of the epic amounts of liquidity created by our central bankers in their desperate and misguided attempts to sustain the economy.

Like Internet stocks in the 1990s, which couldn't be valued on traditional metrics, biotech stocks were the perfect foil. They are the stuff of hopes and dreams. A successful drug can be worth billions. But the odds of success are very low – like one in a thousand. Las Vegas offers better odds (and better attractions).

So Wall Street geared up its PR machine and started pumping out research to sell investors the fantasy of saving mankind through new drug discoveries. It is a wonderful goal – but 99.9% of the time it is a pipedream. Biotech is venture capital by another name. Buying biotech stocks is also gambling by another name when stock prices reach become as overvalued as they have in this market cycle.

Today's biotech stocks should carry the following warning on it for individual investors – "Don't try this at home!" Or perhaps a better warning label would be "Losses are closer than they appear!" Anything is possible, but the rout in these stocks isn't over.

The True Indicator of This Hidden Bear

While biotech was just the latest sector to collapse in what has become a stealth bear market (many stocks are down far more than the 10% that would mark a correction), investors remained obsessed with the Federal Reserve. Janet Yellen attempted to walk back the Fed's confusing remarks of a week ago when she gave a speech on Thursday night (and almost fainted from the strain) and said that she believed there would be a rate hike by the end of the year.

Wow! The Fed is going to raise rates for the first time in nine years by all of 25 basis points in December – if the economic data justifies such a move….That's like saying Donald Trump is going to win the Republican nomination – if he wins enough delegates.

In other words, this is a completely meaningless statement. Moreover, there is little chance that the economic data that the Fed is worried about (i.e. China) is going to improve much at all. So while markets celebrated her remarks with a tepid rally on Friday, the truth is that they really don't know what to think. Remember, it was only a couple of months ago that markets were selling off at the mere hint of a rate hike. This is not a confederacy of dunces – it is a confederacy of idiots.

As a result of all of this confusion, markets didn't do much last week outside the sectors that continued their collapse, including not only biotechs but anything commodities-related. The Dow Jones Industrial Average lost 0.4% or 70 points to close at 16,314.67 while the S&P 500 fell 1.4% or 27 points to end the week at 1931.34. The Nasdaq Composite Index fared much worse on the back of the biotech collapse, losing 3% to close at 4686.50.

Investors should keep their eyes on the stock of Glencore Plc (LON: GLEN.L), the Swiss commodities trading powerhouse that has dropped from a 52-week high of £345.70 to £97.22 as a result of the rout in commodities that began in 2014. Glencore is cutting debt and trying to survive the worst crisis in its brief history as a public company. It is an excellent barometer of the carnage in the commodities space which is nowhere near over.


Money Morning/The Money Map Report

©2015 Monument Street Publishing. All Rights Reserved. Protected by copyright laws of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), of content from this website, in whole or in part, is strictly prohibited without the express written permission of Monument Street Publishing. 105 West Monument Street, Baltimore MD 21201, Email:

Disclaimer: Nothing published by Money Morning should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investent advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication, or after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Money Morning should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

© 2005-2019 - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.

Post Comment

Only logged in users are allowed to post comments. Register/ Log in

6 Critical Money Making Rules